分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Competitive Binding of UBA52 and HOPX Modulates β-catenin Stability in Colorectal Cancer in the Context of High-Iron Intake

Xiangjun Liu, Tong Tang, Xi Wang, Jianhua Feng, XiangJie Yang, Yajun Luo, Yujun Huang, Lu Xu, Banghui Liu, Nan Wang, Yikun Luo, Hefei Tian, Shubin Wang, Lingxiao Huang, Zhenni Xu, Hai Hu, Chao Liu, X

Journal:International Journal of Biological Sciences

IF:11.7

DOI:10.7150/ijbs.126038

PMID:42157941

Published:2026-04-16

research field:肿瘤学分子生物学RNA剪接内分泌学癌症生物学表观遗传学

Abstract

Over-intake of dietary iron and hereditary iron overload are implicated in colorectal cancer (CRC) carcinogenesis, yet the mechanistic basis of how iron-mediated signaling leads to oncogenesis remains enigmatic. Here we demonstrate that high iron diet augments the regenerative capacity of Hopx + intestinal stem cells (ISCs) rather than Lgr5 + ISCs to functionally contribute to colon tumor formation. Mechanistically, high iron activates a robust Wnt/β-catenin signaling in ISCs to enhance the proliferation of colonic cells in a Hopx-dependent manner. Furthermore, Wnt/β-catenin induction is attributed to Hopx stabilizing β-catenin protein by directly inhibiting the interaction of β-catenin with UBA52, which targets ubiquitination degradation of β-catenin. This study thus identifies an iron-triggered pathway regulating intestinal tumorigenesis and indicates that iron interventions may complement current prevention and treatment strategies for CRC, and Hopx is a previously unrecognized regulator of β-catenin and a therapeutic target of CRC.

本文使用的Yeasen产品

购物车
客服
转染试用